You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 22, December 10, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  JAMA Patient Page
 This Article
 •PDF
 •Spanish PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Pain
 •JAMA Patient Page
 •Hematology/ Hematologic Malignancies
 •Anemias
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sickle Cell Vasculopathy

Sickle cell disease affects the red blood cells and is one of the most common genetic (inherited) diseases. It affects 70 000 people in the United States. The normal red blood cell carries oxygen and delivers it to the tissues. Sickle-shaped red blood cells have difficulty traveling through the blood vessels to deliver oxygen to the tissues. These sickle cells are more stiff and can get stuck inside the blood vessels. People with sickle cell disease often have problems caused by blockages of these sickle cells within their blood vessels. Compared with normal red blood cells, sickle cells are more fragile and are often broken up within the blood vessels. When red blood cells are broken, the affected person becomes anemic (low blood count) and may develop a yellow discoloration in the whites of the eyes called jaundice. Pain is a major consequence of red blood cells sickling within the blood vessels. When pain is severe, it is called a sickle cell pain crisis. The contents of the sickle cell released during its breakage can damage the blood vessel wall, resulting in vasculopathy (disorder of the blood vessel wall that further restricts blood circulation to tissues or organs). The December 10, 2008, issue of JAMA includes an article about a person with sickle cell vasculopathy.


Figure 1

SIGNS AND SYMPTOMS

  • Pain in the affected area of the body
  • Fever
  • Acute chest syndrome—pain in the chest associated with cough, shortness of breath, and fever resembling pneumonia
  • Jaundice
  • Lower leg ulcers that are often slow to heal
  • Stroke when a blood vessel in the brain is affected, resulting in lost or reduced function in the affected part of the body
  • Priapism—painful erection that can last more than 4 hours when the blood vessels in the penis are affected
  • Pulmonary hypertension—elevated blood pressure in the artery that carries the blood from the heart to the lungs


TREATMENT

  • Medication to relieve pain
  • Intravenous fluid hydration
  • Oxygen therapy
  • Wound care for ulcers
  • Blood transfusions
  • Hydroxyurea—a drug used to decrease the frequency of pain crises and need for blood transfusions
  • Medications for pulmonary hypertension


PREVENTION

Individuals with sickle cell disease should

  • Drink plenty of fluids
  • Avoid extreme exertion
  • Avoid extremes of temperature
  • Avoid high altitudes
  • Get appropriate vaccinations as recommended by your physician, including an annual influenza vaccine and the pneumococcal vaccine
  • Discuss with your doctor whether hydroxyurea treatment is appropriate for prevention of sickle cell complications


FOR MORE INFORMATION


INFORM YOURSELF

To find this and other JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English, Spanish, and French. A Patient Page on facts about sickle cell disease was published in the May 12, 1999, issue; one on pulmonary hypertension in the January 23, 2008, issue; and one on blood transfusions in the October 6, 2004, issue.

Source: Centers for Disease Control and Prevention

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

TOPIC: SICKLE CELL ANEMIA

Carolyn J. Hildreth, MD, Writer; Alison E. Burke, MA, Illustrator; Richard M. Glass, MD, Editor

JAMA. 2008;300(22):2690.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy
Gregory J. Kato and Mark T. Gladwin
JAMA. 2008;300(22):2638-2646.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.